Program Description:

South Texas has 4.7 million residents (69% are Hispanic/Latino).  Income inequality, poverty, and poorer health outcomes are more widespread in southern states, compared to the rest of the nation.  Nearly 400,000 residents of TX are living with the Hepatitis C virus (HCV), with county-based prevalence rates from 1%-3%.  Texas Department of State Health Services has recently presented data from the Centers for Disease Control and Prevention (CDC) showing that Bexar County is a molecular genetic surveillance epicenter for a cluster of increasing transmission of people living with HIV.  HIV accelerates the progression of liver disease in people co-infected with both HIV and HCV compared to those with HCV only.  It is therefore important that co-infected patients are cured of HCV infection.

Eligibility:

-Agency Intake Completion

-HIV positive

-Hepatitis C positive with confirmatory test result

Non-Insured:

-Eligibility for facility services

Insured:

-We accept all health insurances

Treatment options for Hepatitis C:

– Confirmatory test result

– FibroScan

– Once confirmed, 1 pill a day for 8 to 12 weeks

– Follow up thereafter

Contact information:

Rosetti Hoffman, Project Coordinator

210-688-5795

rosettih@aarcsa.com

Website:

https://wp.uthscsa.edu/tackle/

https://wp.uthscsa.edu/echo/